Increased Susceptibility for Thromboembolic Events versus High Bleeding Risk Associated with COVID-19.

It seems that over time the reported prevalence of thrombotic events shows a decreasing trend and may be less frequently encountered in COVID-19 caused by VOC/VOI than in the earlier strains, possibly also in connection with a larger use of the concomitant ACT during hospitalization, but also for prevention in high-risk outpatients, and during recovery as well, as recommended by several guidelines [ 29 , 30 , 33 , 35 , 37 , 38 ].

also in 47,180 other papers